These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 17786611

  • 1. GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia.
    Turin I, Pedrazzoli P, Tullio C, Montini E, La Grotteria MC, Schiavo R, Perotti C, Locatelli F, Carretto E, Maccario R, Siena S, Montagna D.
    Cytotherapy; 2007; 9(5):499-507. PubMed ID: 17786611
    [Abstract] [Full Text] [Related]

  • 2. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S, Wehler T, Schnürer E, Lennerz V, Brenner W, Melchior S, Gröne M, Nonn M, Strand S, Meyer R, Ranieri E, Huber C, Falk CS, Herr W.
    Cancer Res; 2006 Dec 01; 66(23):11447-54. PubMed ID: 17145892
    [Abstract] [Full Text] [Related]

  • 3. A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2.
    Correale P, Micheli L, Vecchio MT, Sabatino M, Petrioli R, Pozzessere D, Marsili S, Giorgi G, Lozzi L, Neri P, Francini G.
    Br J Cancer; 2001 Nov 30; 85(11):1722-30. PubMed ID: 11742494
    [Abstract] [Full Text] [Related]

  • 4. Manufacturing of gene-modified cytotoxic T lymphocytes for autologous cellular therapy for lymphoma.
    Cooper LJ, Ausubel L, Gutierrez M, Stephan S, Shakeley R, Olivares S, Serrano LM, Burton L, Jensen MC, Forman SJ, DiGiusto DL.
    Cytotherapy; 2006 Nov 30; 8(2):105-17. PubMed ID: 16698684
    [Abstract] [Full Text] [Related]

  • 5. Ex vivo generation and expansion of anti-tumor cytotoxic T-cell lines derived from patients or their HLA-identical sibling.
    Montagna D, Schiavo R, Gibelli N, Pedrazzoli P, Tonelli R, Pagani S, Assirelli E, Locatelli F, Pession A, Fregoni V, Montini E, Da Prada GA, Siena S, Maccario R.
    Int J Cancer; 2004 May 20; 110(1):76-86. PubMed ID: 15054871
    [Abstract] [Full Text] [Related]

  • 6. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells.
    Koido S, Hara E, Homma S, Torii A, Toyama Y, Kawahara H, Watanabe M, Yanaga K, Fujise K, Tajiri H, Gong J, Toda G.
    Clin Cancer Res; 2005 Nov 01; 11(21):7891-900. PubMed ID: 16278414
    [Abstract] [Full Text] [Related]

  • 7. Rapid expansion of tumor-reactive cells from HLA-matched siblings for adoptive immunotherapy of melanoma.
    Gottlieb DJ, Micklethwaite K, Bradstock KF, Li YC.
    Cytotherapy; 2007 Nov 01; 9(2):133-43. PubMed ID: 17453965
    [Abstract] [Full Text] [Related]

  • 8. Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cells.
    Kass R, Bellone S, Palmieri M, Canè S, Bignotti E, Henry-Tillman R, Hutchins L, Cannon MJ, Klimberg S, Santin AD.
    Breast Cancer Res Treat; 2003 Aug 01; 80(3):275-85. PubMed ID: 14503800
    [Abstract] [Full Text] [Related]

  • 9. Generation of Ag-specific cytotoxic T lymphocytes by DC transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA.
    Osman Y, Narita M, Ayres F, Takahashi M, Alldawi L, Tatsuo F, Toba K, Hirohashi T, Aizawa Y.
    Cytotherapy; 2003 Aug 01; 5(2):161-8. PubMed ID: 12745578
    [Abstract] [Full Text] [Related]

  • 10. Tetanus toxoid provides efficient T-cell help for the induction of HA-1(H) cytotoxic T cells.
    Eiz-Vesper B, Horn PA, Daubert C, Khattab B, Blasczyk R.
    Transfusion; 2006 Jul 01; 46(7):1210-20. PubMed ID: 16836569
    [Abstract] [Full Text] [Related]

  • 11. Expansion of human CMV-specific cytotoxic T lymphocytes to a clinical scale: a simple culture system using tetrameric HLA-peptide complexes.
    Watanabe N, Kamachi Y, Koyama N, Hama A, Liang J, Nakamura Y, Yamamoto T, Isomura M, Kudo K, Kuzushima K, Kojima S.
    Cytotherapy; 2004 Jul 01; 6(5):514-22. PubMed ID: 15512918
    [Abstract] [Full Text] [Related]

  • 12. Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety.
    Hammer MH, Brestrich G, Mittenzweig A, Roemhild A, Zwinger S, Subklewe M, Beier C, Kurtz A, Babel N, Volk HD, Reinke P.
    J Immunother; 2007 Jul 01; 30(8):817-24. PubMed ID: 18049333
    [Abstract] [Full Text] [Related]

  • 13. Clinical grade expansion of CD45RA, CD45RO, and CD62L-positive T-cell lines from HLA-compatible donors: high cytotoxic potential against AML and ALL cells.
    Barbui AM, Borleri G, Conti E, Ciocca A, Salvi A, Micò C, Introna M, Rambaldi A.
    Exp Hematol; 2006 Apr 01; 34(4):475-85. PubMed ID: 16569594
    [Abstract] [Full Text] [Related]

  • 14. Autologous dendritic cells loaded with apoptotic tumor cells induce T cell-mediated immune responses against breast cancer in vitro.
    Delirezh N, Moazzeni SM, Shokri F, Shokrgozar MA, Atri M, Kokhaei P.
    Cell Immunol; 2009 Apr 01; 257(1-2):23-31. PubMed ID: 19306994
    [Abstract] [Full Text] [Related]

  • 15. [Autologous tumor specific immunotherapy of refractory cancers with ex vivo-generated T cells stimulated by autologous tumor cell].
    Toh U, Yamana H, Kido K, Mine T, Fujii T, Horiuchi H, Sasatomi T, Ishibashi N, Yutani S, Fujita H, Shirouzu K.
    Gan To Kagaku Ryoho; 2003 Oct 01; 30(11):1566-70. PubMed ID: 14619465
    [Abstract] [Full Text] [Related]

  • 16. Cytotoxic effects of T cells induced by fusion protein 6B11-pulsed dendritic cells on ovarian carcinoma cells.
    Yang W, Feng J, Chang X, Fu T, Ye X, Zhang H, Li X, Wen H, Feng L, Tong C, Cui H.
    Gynecol Oncol; 2007 Apr 01; 105(1):238-43. PubMed ID: 17383546
    [Abstract] [Full Text] [Related]

  • 17. Feasibility and safety of adoptive immunotherapy with ex vivo-generated autologous, cytotoxic T lymphocytes in patients with solid tumor.
    Montagna D, Turin I, Schiavo R, Montini E, Zaffaroni N, Villa R, Secondino S, Schiavetto I, Caliogna L, Locatelli F, Libri V, Pession A, Tonelli R, Maccario R, Siena S, Pedrazzoli P.
    Cytotherapy; 2012 Jan 01; 14(1):80-90. PubMed ID: 21942841
    [Abstract] [Full Text] [Related]

  • 18. Presence of low dose of fludarabine in cultures blocks regulatory T cell expansion and maintains tumor-specific cytotoxic T lymphocyte activity generated with peripheral blood lymphocytes.
    Hegde U, Chhabra A, Chattopadhyay S, Das R, Ray S, Chakraborty NG.
    Pathobiology; 2008 Jan 01; 75(3):200-8. PubMed ID: 18550918
    [Abstract] [Full Text] [Related]

  • 19. Transfer of in vitro expanded T lymphocytes after activation with dendritomas prolonged survival of mice challenged with EL4 tumor cells.
    Li J, Theofanous L, Stickel S, Bouton-Verville H, Burgin KE, Jakubchak S, Wagner TE, Wei Y.
    Int J Oncol; 2007 Jul 01; 31(1):193-7. PubMed ID: 17549421
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-15 favors the expansion of central memory CD8+ T cells in ex vivo generated, antileukemia human cytotoxic T lymphocyte lines.
    Daudt L, Maccario R, Locatelli F, Turin I, Silla L, Montini E, Percivalle E, Giugliani R, Avanzini MA, Moretta A, Montagna D.
    J Immunother; 2008 May 01; 31(4):385-93. PubMed ID: 18391757
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.